-
Something wrong with this record ?
Engineered N-acetylhexosamine-active enzymes in glycoscience
K. Slámová, P. Bojarová,
Language English Country Netherlands
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
- MeSH
- Glycoproteins biosynthesis MeSH
- Glycoside Hydrolases metabolism MeSH
- Glycosylation MeSH
- Glycosyltransferases metabolism MeSH
- Hexosamines metabolism MeSH
- Catalysis MeSH
- Oligosaccharides biosynthesis MeSH
- Protein Engineering * MeSH
- Sulfotransferases metabolism MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
BACKGROUND: In recent years, enzymes modifying N-acetylhexosamine substrates have emerged in numerous theoretical studies as well as practical applications from biology, biomedicine, and biotechnology. Advanced enzyme engineering techniques converted them into potent synthetic instruments affording a variety of valuable glycosides. SCOPE OF REVIEW: This review presents the diversity of engineered enzymes active with N-acetylhexosamine carbohydrates: from popular glycoside hydrolases and glycosyltransferases to less known oxidases, epimerases, kinases, sulfotransferases, and acetylases. Though hydrolases in natura, engineered chitinases, β-N-acetylhexosaminidases, and endo-β-N-acetylglucosaminidases were successfully employed in the synthesis of defined natural and derivatized chitooligomers and in the remodeling of N-glycosylation patterns of therapeutic antibodies. The genes of various N-acetylhexosaminyltransferases were cloned into metabolically engineered microorganisms for producing human milk oligosaccharides, Lewis X structures, and human-like glycoproteins. Moreover, mutant N-acetylhexosamine-active glycosyltransferases were applied, e.g., in the construction of glycomimetics and complex glycostructures, industrial production of low-lactose milk, and metabolic labeling of glycans. In the synthesis of biotechnologically important compounds, several innovative glycoengineered systems are presented for an efficient bioproduction of GlcNAc, UDP-GlcNAc, N-acetylneuraminic acid, and of defined glycosaminoglycans. MAJOR CONCLUSIONS: The above examples demonstrate that engineering of N-acetylhexosamine-active enzymes was able to solve complex issues such as synthesis of tailored human-like glycoproteins or industrial-scale production of desired oligosaccharides. Due to the specific catalytic mechanism, mutagenesis of these catalysts was often realized through rational solutions. GENERAL SIGNIFICANCE: Specific N-acetylhexosamine glycosylation is crucial in biological, biomedical and biotechnological applications and a good understanding of its details opens new possibilities in this fast developing area of glycoscience.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016699
- 003
- CZ-PrNML
- 005
- 20190906121858.0
- 007
- ta
- 008
- 180515s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bbagen.2017.03.019 $2 doi
- 035 __
- $a (PubMed)28347843
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Slámová, Kristýna $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Prague 4, Czech Republic.
- 245 10
- $a Engineered N-acetylhexosamine-active enzymes in glycoscience / $c K. Slámová, P. Bojarová,
- 520 9_
- $a BACKGROUND: In recent years, enzymes modifying N-acetylhexosamine substrates have emerged in numerous theoretical studies as well as practical applications from biology, biomedicine, and biotechnology. Advanced enzyme engineering techniques converted them into potent synthetic instruments affording a variety of valuable glycosides. SCOPE OF REVIEW: This review presents the diversity of engineered enzymes active with N-acetylhexosamine carbohydrates: from popular glycoside hydrolases and glycosyltransferases to less known oxidases, epimerases, kinases, sulfotransferases, and acetylases. Though hydrolases in natura, engineered chitinases, β-N-acetylhexosaminidases, and endo-β-N-acetylglucosaminidases were successfully employed in the synthesis of defined natural and derivatized chitooligomers and in the remodeling of N-glycosylation patterns of therapeutic antibodies. The genes of various N-acetylhexosaminyltransferases were cloned into metabolically engineered microorganisms for producing human milk oligosaccharides, Lewis X structures, and human-like glycoproteins. Moreover, mutant N-acetylhexosamine-active glycosyltransferases were applied, e.g., in the construction of glycomimetics and complex glycostructures, industrial production of low-lactose milk, and metabolic labeling of glycans. In the synthesis of biotechnologically important compounds, several innovative glycoengineered systems are presented for an efficient bioproduction of GlcNAc, UDP-GlcNAc, N-acetylneuraminic acid, and of defined glycosaminoglycans. MAJOR CONCLUSIONS: The above examples demonstrate that engineering of N-acetylhexosamine-active enzymes was able to solve complex issues such as synthesis of tailored human-like glycoproteins or industrial-scale production of desired oligosaccharides. Due to the specific catalytic mechanism, mutagenesis of these catalysts was often realized through rational solutions. GENERAL SIGNIFICANCE: Specific N-acetylhexosamine glycosylation is crucial in biological, biomedical and biotechnological applications and a good understanding of its details opens new possibilities in this fast developing area of glycoscience.
- 650 _2
- $a katalýza $7 D002384
- 650 _2
- $a glykoproteiny $x biosyntéza $7 D006023
- 650 _2
- $a glykosidhydrolasy $x metabolismus $7 D006026
- 650 _2
- $a glykosylace $7 D006031
- 650 _2
- $a glykosyltransferasy $x metabolismus $7 D016695
- 650 _2
- $a hexosaminy $x metabolismus $7 D006595
- 650 _2
- $a oligosacharidy $x biosyntéza $7 D009844
- 650 12
- $a proteinové inženýrství $7 D015202
- 650 _2
- $a sulfotransferasy $x metabolismus $7 D015238
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Bojarová, Pavla $u Laboratory of Biotransformation, Institute of Microbiology, Czech Academy of Sciences, Vídeňská 1083, CZ 14220 Prague 4, Czech Republic. Electronic address: bojarova@biomed.cas.cz.
- 773 0_
- $w MED00000717 $t Biochimica et biophysica acta. G, General subjects $x 0304-4165 $g Roč. 1861, č. 8 (2017), s. 2070-2087
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28347843 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20190906122231 $b ABA008
- 999 __
- $a ok $b bmc $g 1300323 $s 1013539
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 1861 $c 8 $d 2070-2087 $e 20170327 $i 0304-4165 $m Biochimica et biophysica acta. G, General subjects $n Biochem Biophys Acta $x MED00000717
- LZP __
- $a Pubmed-20180515